Skip to main content
Clinical Trials/NCT02951624
NCT02951624CompletedNot Applicable

The Effect of Frequency and Duration of Breaks in Sitting Time on Metabolic Cardiovascular Risk Factors

Rigshospitalet, Denmark1 site in 1 country14 target enrollmentStarted: November 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
14
Locations
1
Primary Endpoint
AUC post prandial glucose concentration

Study Overview

Brief Summary

The primary aim of this study is to investigate the acute effect of the frequency and duration of breaks in sitting time on the metabolic risk factor profile.

Detailed Description

Fifteen (n=15) sedentary adult overweight males will be included in the study. All participants will undergo the four interventions in a randomized cross-over design. Wash out between intervention will be minimum four days.

Control (CON): Participants will be sedentary. Sedentary time will be spent sitting in a chair, restricted to sedentary behaviors (working on a computer, reading, watching TV, etc.), with a target MET below 1.5 (i.e. 1.5 times REE). Participants will only be allowed to stand or walk to go to the toilet.

Breaker: Participants will be breaking up prolonged sitting with 2 min intervals of low intensity walking.

Intermediate: Participants will be breaking up prolonged sitting with 6 min intervals of low intensity walking

Prolonger: Participants will be breaking up prolonged sitting with 12 min intervals of low intensity walking

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Males, age 20-50 years, waist-to-height ratio ≥ 0.5 and/or waist circumference ≥ 102 cm.

Exclusion Criteria

  • •Clinically diagnosed diabetes, uncontrolled hypertension, use of glucose- and/or lipid-lowering medication, smoking, evidence of thyroid, liver, lung, heart or kidney disease, non-sedentary occupation, and VO2max levels above the considered average fitness according to age (Shvartz & Reibold 1990), contraindications to increased levels of physical activity.

Arms & Interventions

Control

Experimental

Participants will spend 8 hours sedentary. Sedentary time will be spent sitting in a chair, restricted to sedentary behaviors (working on a computer, reading, watching TV, etc.) Participants will only be allowed to stand or walk to go to the toilet.

Intervention: Control (Behavioral)

Breaker

Experimental

Participants will spend a total of 7 hours and 12 min sedentary and a total of 48 min breaking sitting time with LPA. Sedentary time will be done in bouts of 18 min with 2 min of light walking.

Intervention: Breaker (Behavioral)

Intermediate

Experimental

Total duration of sedentary time and LPA time will be the same as in Breaker. Sedentary time will be done in bouts of 54 min with 6 min of LPA between each bout.

Intervention: Intermediate (Behavioral)

Prolonger

Experimental

Total duration of sedentary time and LPA time will be the same as in Breaker. Sedentary time will be done in bouts of 108 min with 12 min of LPA between each bout.

Intervention: Prolonger (Behavioral)

Outcomes

Primary Outcomes

AUC post prandial glucose concentration

Time Frame: 6 hours

Secondary Outcomes

  • AUC post prandial hdl concentration(6 hours)
  • Mean 24 hour glucose concentration(24 hours)
  • AUC post prandial insulin concentration(6 hours)
  • AUC post prandial c-peptide concentration(6 hours)
  • AUC post prandial glucagon concentration(6 hours)
  • Variation in 24 hour glucose concentration(24 hours)
  • AUC post prandial triglyceride concentration(6 hours)
  • AUC post prandial ldl concentration(6 hours)
  • AUC post prandial total cholesterol concentration(6 hours)
  • Maximum in 24 hour glucose concentration(24 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mathias Ried-Larsen

Group leader

Rigshospitalet, Denmark

Study Sites (1)

Loading locations...

Similar Trials